甲磺酸多沙唑嗪片，1.原发性轻、中度高血压。对于单独用药难以控制血压的患者，可与利尿剂、β受体阻滞剂、钙拮抗剂或血管紧张素转化酶抑制剂(ACEI)合用。2.良性前列腺增生的对症治疗。
甲磺酸多沙唑嗪片 （Doxazosin Mesylate Tablets）届国家二类新药。本品为选择性α 肾上腺素受体阻滞剂。
基于266个网页-相关网页
甲磺酸多沙唑嗪片制剂处方工艺探讨--(制剂与技术) 关键词] 甲磺酸多沙唑嗪片；处方；含量；溶出度 [gap=1291]Key words] Mesylate doxazosin tablets; Prescription; Content; Dissolution
基于34个网页-相关网页
甲磺酸多沙唑嗪控释片 Doxazosin Mesylate Controlled Release Tablets ; Cardura XL
甲磺酸多沙唑嗪缓释片 CarduraXL ; Doxazosin Mesylate Extended Release Tablets ; Doxazosin Mesylate Extended-release Tablets
结论：甲磺酸多沙唑嗪片降压作用稳定，患者依从性较好。
Conclusion: Doxazosin has stable hypotensive effect and the patients compliance is good.
结论甲磺酸多沙唑嗪片与盐酸特拉唑嗪片疗效相似，是治疗轻中度原发性高血压安全、有效的药物。
Conclusions Both doxazosin and terazosin were effective and safe for the treatment of mild and moderate primary hypertension.
本发明提供了一种甲磺酸多沙唑嗪双层渗透泵控释片。
The invention provides a doxazosin mesylate bi-layer osmotic pump controlled release tablet.
应用推荐